The FINANCIAL — EFPIA, the voice of the research-based pharmaceutical industry in Europe, supports the idea to establish a “European Council for Health Research”, launched last week by the Alliance for Biomedical Research in Europe representing 16 leading European biomedical research societies, according to EFPIA.
This call for action by the biomedical research community coincides with the publication by the European Commission of the next EU research funding framework “Horizon 2020”.
Richard Bergström, Director General of EFPIA, said: “We agree with the BioMed Alliance that success and innovation in health research requires a long-term commitment. I warmly welcome this initiative, which is a step towards a European “National Institute of Health”. Such a European body would allow both strategic long-term planning driven by healthcare needs and optimising healthcare delivery across Europe through high level treatment guidelines and a shared understanding on how health technology assessments can deliver value for money”.
“EFPIA is ready to engage into a stakeholder debate proposed by the BioMed Alliance on how to structure a European Council for Health research to optimise healthcare research and delivery across Europe” – concluded Richard Bergström.